Korman, A. J., Garrett-Thomson, S. C. & Lonberg, N. The foundations of immune checkpoint blockade and the ipilimumab approval decennial. Nat. Rev. Drug Discov. 21, 509–528 (2022).
Chowell, D. et al. Improved prediction of immune checkpoint blockade efficacy throughout a number of most cancers varieties. Nat. Biotechnol. 40, 499–506 (2022).
Genova, C. et al. Therapeutic implications of tumor microenvironment in lung most cancers: deal with immune checkpoint blockade. Entrance. Immunol. 12, 799455 (2022).
Huang, A. C. & Zappasodi, R. A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular foundation for immune sensitivity and resistance. Nat. Immunol. 23, 660–670 (2022).
Falcomatà, C. et al. Context-specific determinants of the immunosuppressive tumor microenvironment in pancreatic most cancers. Most cancers Discov. 13, 278–297 (2023).
Budczies, J. et al. Deciphering the immunosuppressive tumor microenvironment in ALK-and EGFR-positive lung adenocarcinoma. Most cancers Immunol. Immunother. 71, 251–265 (2022).
Ajona, D. et al. Quick-term hunger reduces IGF-1 ranges to sensitize lung tumors to PD-1 immune checkpoint blockade. Nat. Most cancers 1, 75–85 (2020).
DeVito, N. C. et al. Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy. Cell Rep. 35, 109071 (2021).
Wang, X. et al. EGFR is a grasp change between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast most cancers. Sci. Adv. 8, eabn7983 (2022).
Xie, Q.-H. et al. Exosome-mediated immunosuppression in tumor microenvironments. Cells 11, 1946 (2022).
Wculek, S. Okay. et al. Dendritic cells in most cancers immunology and immunotherapy. Nat. Rev. Immunol. 20, 7–24 (2020).
Yin, Y. et al. In situ reworking RNA nanovaccines from polyethylenimine functionalized graphene oxide hydrogel for sturdy most cancers immunotherapy. Nano Lett. 21, 2224–2231 (2021).
Mohammadzadeh, Y. & De Palma, M. Boosting dendritic cell nanovaccines. Nat. Nanotechnol. 17, 442–444 (2022).
Sellars, M. C., Wu, C. J. & Fritsch, E. F. Most cancers vaccines: constructing a bridge over troubled waters. Cell 185, 2770–2788 (2022).
Steinman, R. M. Selections about dendritic cells: previous, current, and future. Annu. Rev. Immunol. 30, 1–22 (2012).
Møller, S. H., Wang, L. & Ho, P.-C. Metabolic programming in dendritic cells tailors immune responses and homeostasis. Cell. Mol. Immunol. 19, 370–383 (2022).
Barbet, G. et al. The calcium-activated nonselective cation channel TRPM4 is important for the migration however not the maturation of dendritic cells. Nat. Immunol. 9, 1148–1156 (2008).
Zsiros, E. et al. Developmental change of the expression of ion channels in human dendritic cells. J. Immunol. 183, 4483–4492 (2009).
Lu, X., Oh-Hora, M., Takeda, Okay. & Yamasaki, S. Selective suppression of IL-10 transcription by calcineurin in dendritic cells by way of inactivation of CREB. Int. Immunol. 34, 197–206 (2022).
Vaeth, M. et al. Ca2+ signaling however not store-operated Ca2+ entry is required for the perform of macrophages and dendritic cells. J. Immunol. 195, 1202–1217 (2015).
Crottès, D. et al. Immature human dendritic cells improve their migration by way of KCa3.1 channel activation. Cell Calcium 59, 198–207 (2016).
Duo, L. et al. Achieve of perform of ion channel TRPV1 exacerbates experimental colitis by selling dendritic cell activation. Mol. Ther. Nucleic Acids 22, 924–936 (2020).
Barth, A. & Zscherp, C. What vibrations inform about proteins. Q. Rev. Biophys. 35, 369–430 (2002).
Fan, Z., Solar, L., Huang, Y., Wang, Y. & Zhang, M. Bioinspired fluorescent dipeptide nanoparticles for focused most cancers cell imaging and real-time monitoring of drug launch. Nat. Nanotechnol. 11, 388–394 (2016).
Fleming, S. et al. Assessing the utility of infrared spectroscopy as a structural diagnostic software for β-sheets in self-assembling fragrant peptide amphiphiles. Langmuir 29, 9510–9515 (2013).
Bröer, S. Amino acid transporters as targets for most cancers remedy: why, the place, when, and the way. Int. J. Mol. Sci. 21, 6156 (2020).
Bannunah, A. M., Vllasaliu, D., Lord, J. & Stolnik, S. Mechanisms of nanoparticle internalization and transport throughout an intestinal epithelial cell mannequin: impact of dimension and floor cost. Mol. Pharmacol. 11, 4363–4373 (2014).
Muñoz-Planillo, R. et al. Okay+ efflux is the frequent set off of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38, 1142–1153 (2013).
Han, C. et al. The AIM2 and NLRP3 inflammasomes set off IL-1-mediated antitumor results throughout radiation. Sci. Immunol. 6, eabc6998 (2021).
Swanson, Okay. V., Deng, M. & Ting, J. P.-Y. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19, 477–489 (2019).
Bai, H. et al. Cathepsin B hyperlinks oxidative stress to the activation of NLRP3 inflammasome. Exp. Cell Res. 362, 180–187 (2018).
Chandy, Okay. G. & Norton, R. S. Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune illness. Curr. Opin. Chem. Biol. 38, 97–107 (2017).
Yoshioka, Okay. & Moeder, W. Calcium channel in vegetation helps shut the door on intruders. Nature 585, 507–508 (2020).
Edin, S., Oruganti, S. R., Grundström, C. & Grundström, T. Interplay of calmodulin with Bcl10 modulates NF-κB activation. Mol. Immunol. 47, 2057–2064 (2010).
Han, Y. et al. Modulatory perform of calmodulin on phagocytosis and potential regulation mechanisms within the blood clam Tegillarca granosa. Dev. Comp. Immunol. 116, 103910 (2021).
Berry, C. T., Might, M. J. & Freedman, B. D. STIM- and Orai-mediated calcium entry controls NF-κB exercise and performance in lymphocytes. Cell Calcium 74, 131–143 (2018).
Zhang, T., Ma, C., Zhang, Z., Zhang, H. & Hu, H. NF‐κB signaling in irritation and most cancers. MedComm 2, 618–653 (2021).
Chen, Q. et al. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical most cancers therapy. Nat. Nanotechnol. 14, 89–97 (2019).
Miller, B. C. et al. Subsets of exhausted CD8+ T cells differentially mediate tumor management and reply to checkpoint blockade. Nat. Immunol. 20, 326–336 (2019).
Jackson, W. F. KV1.3: a brand new therapeutic goal to regulate vascular easy muscle cell proliferation. Arterioscler. Thromb. Vasc. Biol. 30, 1073–1074 (2010).
Webb, B. & Sali, A. Protein construction modeling with MODELLER. Strategies Mol. Biol. 1137, 1–15 (2014).
Selvakumar, P. et al. Constructions of the T cell potassium channel Kv1.3 with immunoglobulin modulators. Nat. Commun. 13, 3854 (2022).
Goodsell, D. S., Sanner, M. F., Olson, A. J. & Forli, S. The AutoDock suite at 30. Protein Sci. 30, 31–43 (2021).
Almagro, J. C. et al. Antibody modeling evaluation. Proteins 79, 3050–3066 (2011).
Tune, L. F., Lee, T. S., Zhu, C., York, D. M. & Merz, Okay. M.Jr Utilizing AMBER18 for relative free vitality calculations. J. Chem. Inf. Mannequin. 59, 3128–3135 (2019).
Holmgren, M., Shin, Okay. S. & Yellen, G. The activation gate of a voltage-gated Okay+ channel may be trapped within the open state by an intersubunit metallic bridge. Neuron 21, 617–621 (1998).
Wang, W. et al. Twin-targeting nanoparticle vaccine elicits a therapeutic antibody response towards continual hepatitis B. Nat. Nanotechnol. 15, 406–416 (2020).
Jin, H. et al. Genetic fate-mapping reveals floor accumulation however not deep organ invasion of pleural and peritoneal cavity macrophages following damage. Nat. Commun. 12, 2863 (2021).